Minocycline

Chemical formula: C₂₃H₂₇N₃O₇  Molecular mass: 457.476 g/mol  PubChem compound: 54675783

Therapeutic indications

Minocycline is indicated for:

Gonorrhoea

Population group: only adults (18 years old or older)

Gonorrhea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nongonococcal urethritis

Population group: only adults (18 years old or older)

Nongonococcal urethritis and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prostatitis

Population group: men, only adults (18 years old or older)

Prostatitis and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acne

Population group: only adults (18 years old or older)

Moderate to severe acne; use in moderate acne only if topical treatment is ineffective, if acne is extensive or hard to reach and if there is a high risk of scarring.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bronchitis

Population group: only adults (18 years old or older)

Acute and chronic bronchitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bronchiectasis

Population group: only adults (18 years old or older)

Bronchiectasis and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lung abscess

Population group: only adults (18 years old or older)

Abscess of lung and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pneumonia

Population group: only adults (18 years old or older)

Pneumonia and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ear, nose, throat infections

Population group: only adults (18 years old or older)

at least one of
Ear infection
Nasal infection
Upper respiratory infection
and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary tract infections

Population group: only adults (18 years old or older)

Urinary tract infectious disease and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pelvic inflammatory disease

Population group: only adults (18 years old or older)

Pelvic inflammatory disease (eg salpingitis, oophoritis).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Skin and soft tissue infections

Population group: only adults (18 years old or older)

Soft tissue infection and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ophthalmic infections

Population group: only adults (18 years old or older)

Eye infection and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nocardiosis

Population group: only adults (18 years old or older)

Nocardiosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of meningitis

Population group: only adults (18 years old or older)

Prophylaxis of asymptomatic meningococcal carriers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pre-operative and post-operative prophylaxis of infection

Population group: only adults (18 years old or older)

Infectious disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gonorrhoea

Population group: only adolescents (12 years - 18 years old)

Gonorrhea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nongonococcal urethritis

Population group: only adolescents (12 years - 18 years old)

Nongonococcal urethritis and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acne

Population group: only adolescents (12 years - 18 years old)

Moderate to severe acne; use in moderate acne only if topical treatment is ineffective, if acne is extensive or hard to reach and if there is a high risk of scarring.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bronchitis

Population group: only adolescents (12 years - 18 years old)

Acute and chronic bronchitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bronchiectasis

Population group: only adolescents (12 years - 18 years old)

Bronchiectasis and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lung abscess

Population group: only adolescents (12 years - 18 years old)

Abscess of lung and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pneumonia

Population group: only adolescents (12 years - 18 years old)

Pneumonia and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ear, nose, throat infections

Population group: only adolescents (12 years - 18 years old)

at least one of
Ear infection
Nasal infection
Upper respiratory infection
and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary tract infections

Population group: only adolescents (12 years - 18 years old)

Urinary tract infectious disease and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pelvic inflammatory disease

Population group: only adolescents (12 years - 18 years old)

Pelvic inflammatory disease (eg salpingitis, oophoritis).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Skin and soft tissue infections

Population group: only adolescents (12 years - 18 years old)

Soft tissue infection and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ophthalmic infections

Population group: only adolescents (12 years - 18 years old)

Eye infection and additionally Minocycline susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Nocardiosis

Population group: only adolescents (12 years - 18 years old)

Nocardiosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of meningitis

Population group: only adolescents (12 years - 18 years old)

Prophylaxis of asymptomatic meningococcal carriers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pre-operative and post-operative prophylaxis of infection

Population group: only adolescents (12 years - 18 years old)

Infectious disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Periodontitis

Population group: only adults (18 years old or older)

Minocycline is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. Minocycline may be used as part of a periodontal maintenance program which includes good oral hygiene and scaling and root planing.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Minocycline is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Hypersensitivity to minocycline

at least one of
Minocycline allergy
Minocycline adverse reaction

Severe renal failure

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL) 2020: ARESTIN Powder for solution for injection
Summary of Product Characteristics (SPC) 2019: MINOCYCLINE Film-coated tablet
Summary of Product Characteristics (SPC) 2014: ACNAMINO MR Capsule, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈